These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 18587388)

  • 21. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
    Gong CX; Liu F; Iqbal K
    Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enriched odor exposure decrease tau phosphorylation in the rat hippocampus and cortex.
    Liao K; Liu D; Zhu LQ
    Neurosci Lett; 2012 Jan; 507(1):22-6. PubMed ID: 22155098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological Inhibition of O-GlcNAcase Enhances Autophagy in Brain through an mTOR-Independent Pathway.
    Zhu Y; Shan X; Safarpour F; Erro Go N; Li N; Shan A; Huang MC; Deen M; Holicek V; Ashmus R; Madden Z; Gorski S; Silverman MA; Vocadlo DJ
    ACS Chem Neurosci; 2018 Jun; 9(6):1366-1379. PubMed ID: 29460617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both secreted and the cellular levels of BDNF attenuated due to tau hyperphosphorylation in primary cultures of cortical neurons.
    Atasoy İL; Dursun E; Gezen-Ak D; Metin-Armağan D; Öztürk M; Yılmazer S
    J Chem Neuroanat; 2017 Mar; 80():19-26. PubMed ID: 27914953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Turning down tau phosphorylation.
    Fischer PM
    Nat Chem Biol; 2008 Aug; 4(8):448-9. PubMed ID: 18641620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
    Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
    J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
    Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation.
    Yuzwa SA; Shan X; Macauley MS; Clark T; Skorobogatko Y; Vosseller K; Vocadlo DJ
    Nat Chem Biol; 2012 Feb; 8(4):393-9. PubMed ID: 22366723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of MK-8719, a Potent O-GlcNAcase Inhibitor as a Potential Treatment for Tauopathies.
    Selnick HG; Hess JF; Tang C; Liu K; Schachter JB; Ballard JE; Marcus J; Klein DJ; Wang X; Pearson M; Savage MJ; Kaul R; Li TS; Vocadlo DJ; Zhou Y; Zhu Y; Mu C; Wang Y; Wei Z; Bai C; Duffy JL; McEachern EJ
    J Med Chem; 2019 Nov; 62(22):10062-10097. PubMed ID: 31487175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic noise exposure causes persistence of tau hyperphosphorylation and formation of NFT tau in the rat hippocampus and prefrontal cortex.
    Cui B; Zhu L; She X; Wu M; Ma Q; Wang T; Zhang N; Xu C; Chen X; An G; Liu H
    Exp Neurol; 2012 Dec; 238(2):122-9. PubMed ID: 22971273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization.
    Lefebvre T; Ferreira S; Dupont-Wallois L; Bussière T; Dupire MJ; Delacourte A; Michalski JC; Caillet-Boudin ML
    Biochim Biophys Acta; 2003 Jan; 1619(2):167-76. PubMed ID: 12527113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
    Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
    Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GlcNAcstatin: a picomolar, selective O-GlcNAcase inhibitor that modulates intracellular O-glcNAcylation levels.
    Dorfmueller HC; Borodkin VS; Schimpl M; Shepherd SM; Shpiro NA; van Aalten DM
    J Am Chem Soc; 2006 Dec; 128(51):16484-5. PubMed ID: 17177381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.
    Liu F; Shi J; Tanimukai H; Gu J; Gu J; Grundke-Iqbal I; Iqbal K; Gong CX
    Brain; 2009 Jul; 132(Pt 7):1820-32. PubMed ID: 19451179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of O-GlcNAc alteration on Alzheimer-like neurodegeneration in SK-N-SH cells.
    Ding N; Peng P; Chu YJ; Wang JJ; Chen SY; Arulthas R; Deng YQ
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):243-248. PubMed ID: 30181664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific tau phosphorylation sites in hippocampus correlate with impairment of step-down inhibitory avoidance task in rats.
    Chen YG
    Behav Brain Res; 2005 Mar; 158(2):277-84. PubMed ID: 15698894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture.
    Li X; Lu F; Tian Q; Yang Y; Wang Q; Wang JZ
    J Neural Transm (Vienna); 2006 Jan; 113(1):93-102. PubMed ID: 15959856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of human tau 3D structure, and interplay between O-β-GlcNAc and phosphorylation modifications in Alzheimer's disease: C. elegans as a suitable model to study these interactions in vivo.
    Ahmad W; Shabbiri K; Ahmad I
    Biochem Biophys Res Commun; 2020 Jul; 528(3):466-472. PubMed ID: 32499112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SIRT1 deficiency increases O-GlcNAcylation of tau, mediating synaptic tauopathy.
    Yin X; Li Y; Fan X; Huang F; Qiu Y; Zhao C; Zhou Z; Gu Q; Xia L; Bao J; Wang X; Liu F; Qian W
    Mol Psychiatry; 2022 Oct; 27(10):4323-4334. PubMed ID: 35879403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.